Liver involvement occurs in approximately 75% of people with HHT. While many people are asymptomatic, the complications associated with liver involvement have historically been under diagnosed. These complications include arterioportal shunting leading to portal hypertension and arteriosystemic shunting leading to high output cardiac failure (HOCF). HOCF occurs much more frequently than has previously been considered.…

Dr. Justin McWilliams, Co-Director, UCLA HHT Center of Excellence and Katie Wusik, Genetic Counselor for the Cincinnati Children’s Hospital HHT Center of Excellence discuss diagnosing HHT. Dr. McWilliams and Ms. Wusik walk the audience through how a diagnosis is typically confirmed on the basis of clinical features, in people with symptoms, OR with genetic testing, in asymptomatic…

Dr. Jay Piccirillo, ENT, Washington University HHT Center of Excellence and Dr. James Gossage, Director, Augusta University HHT Center of Excellence discuss the new International HHT Guidelines for Epistaxis (Nosebleed Management). Both doctors are renowned HHT specialist in their fields and walk the audience through the guideline recommendations for nosebleed management. With 90% of the HHT population…

La Dra. Yesica Lijdens, Otorrinolaringóloga de la Unidad HHT Hospital Italiano de Buenos Aires, y el Dr. Federico Urquiola, Otorrinolaringólogo y Coordinador ORL de la Unidad HHT Hospital Italiano de Buenos Aires, brindan información sobre cómo tratar la epistaxis en HHT y sus abordajes quirúrgicos. También revisan para la audiencia las recomendaciones de las nuevas…

Dr. Kevin Whitehead, Co-Director, University of Utah HHT Center of Excellence and Dr. Josanna Rodriguez-Lopez, Director, Massachusetts General Hospital HHT Center of Excellence discuss Liver Vascular Malformations (VMs) as they relate to HHT. Both doctors are renowned HHT specialist in their fields and will walk the audience through a comprehensive overview of what a liver…